Recent Financing
Recent Raise
Crystalys Therapeutics is a clinical-stage biopharmaceutical company developing dotinurad, a once-daily oral URAT1 inhibitor for the treatment of gout.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Crystalys Therapeutics.
